Cargando…

Aptamers Enhance Oncolytic Viruses’ Antitumor Efficacy

Oncolytic viruses are highly promising for cancer treatment because they target and lyse tumor cells. These genetically engineered vectors introduce therapeutic or immunostimulatory genes into the tumor. However, viral therapy is not always safe and effective. Several problems are related to oncolyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dymova, Maya A., Kichkailo, Anna S., Kuligina, Elena V., Richter, Vladimir A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864469/ https://www.ncbi.nlm.nih.gov/pubmed/36678780 http://dx.doi.org/10.3390/pharmaceutics15010151

Ejemplares similares

Molecular Mechanisms of Drug Resistance in Glioblastoma
por: Dymova, Maya A., et al.
Publicado: (2021)

Transcriptome Changes in Glioma Cells upon Infection with the Oncolytic Virus VV-GMCSF-Lact
por: Semenov, Dmitriy V., et al.
Publicado: (2023)

Aptamers for Addressed Boron Delivery in BNCT: Effect of Boron Cluster Attachment Site on Functional Activity
por: Novopashina, Darya S., et al.
Publicado: (2022)

Tumor Cell-Specific 2′-Fluoro RNA Aptamer Conjugated with Closo-Dodecaborate as A Potential Agent for Boron Neutron Capture Therapy
por: Vorobyeva, Mariya A., et al.
Publicado: (2021)

Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells
por: Dmitrieva, Maria D., et al.
Publicado: (2020)

Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy
por: Kochneva, Galina, et al.
Publicado: (2016)

Boron neutron capture therapy: Current status and future perspectives
por: Dymova, Mayya Alexandrovna, et al.
Publicado: (2020)

Reporter Transgenes for Monitoring the Antitumor Efficacy of Recombinant Oncolytic Viruses
por: Semenova, A. V., et al.
Publicado: (2022)

Modification of a Tumor-Targeting Bacteriophage for Potential Diagnostic Applications
por: Dymova, Maya Alexandrovna, et al.
Publicado: (2021)

Optimizing Oncolytic Viral Design to Enhance Antitumor Efficacy: Progress and Challenges
por: Chaurasiya, Shyambabu, et al.
Publicado: (2020)

Updates to the antitumor mechanism of oncolytic virus
por: Bai, Yang, et al.
Publicado: (2019)

Tumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of Lactaptin
por: Nemudraya, Anna A., et al.
Publicado: (2016)

Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing Antibodies
por: Muharemagic, Darija, et al.
Publicado: (2014)

Aptamers Regulating the Hemostasis System
por: Vaganov, Anatoly A., et al.
Publicado: (2022)

Current strategies in engaging oncolytic viruses with antitumor immunity
por: Boagni, Drew Ashton, et al.
Publicado: (2021)

Aptamers Increase Biocompatibility and Reduce the Toxicity of Magnetic Nanoparticles Used in Biomedicine
por: Zamay, Galina S., et al.
Publicado: (2020)

Bacteriophage-Mediated Cancer Gene Therapy
por: Petrov, Gleb, et al.
Publicado: (2022)

Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
por: Ma, Jing, et al.
Publicado: (2021)

Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy
por: Zhang, Bin, et al.
Publicado: (2020)

Neoadjuvant Use of Oncolytic Herpes Virus G47Δ Enhances the Antitumor Efficacy of Radiofrequency Ablation
por: Yamada, Tomoharu, et al.
Publicado: (2020)

Post-Transcriptional Modifications of RNA as Regulators of Apoptosis in Glioblastoma
por: Dome, Anton, et al.
Publicado: (2022)

Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
por: Hirvinen, Mari, et al.
Publicado: (2016)

Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL‐24 gene in liver cancer cells
por: Wang, Chunming, et al.
Publicado: (2020)

Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy
por: Ahn, Hyo Min, et al.
Publicado: (2016)

Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice
por: Chen, Nanhai G, et al.
Publicado: (2011)

Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
por: Yokoda, Raquel, et al.
Publicado: (2017)

The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors
por: Young, Brittany A., et al.
Publicado: (2013)

MicroRNA and mRNA Expression Changes in Glioblastoma Cells Cultivated under Conditions of Neurosphere Formation
por: Dymova, Maya A., et al.
Publicado: (2022)

Novel Complex of PD-L1 Aptamer and Albumin Enhances Antitumor Efficacy In Vivo
por: An, Yacong, et al.
Publicado: (2022)

Mesenchymal stem cell carriers enhance antitumor efficacy of oncolytic adenoviruses in an immunocompetent mouse model
por: Rincón, Esther, et al.
Publicado: (2017)

Transcriptome Changes in Glioma Cells Cultivated under Conditions of Neurosphere Formation
por: Vasileva, Natalia S., et al.
Publicado: (2022)

Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safety
por: Ge, Yan, et al.
Publicado: (2020)

Cytotoxic and Antitumor Activity of Lactaptin in Combination with Autophagy Inducers and Inhibitors
por: Bagamanshina, Anastasia V., et al.
Publicado: (2019)

An oncolytic virus expressing a full-length antibody enhances antitumor innate immune response to glioblastoma
por: Xu, Bo, et al.
Publicado: (2021)

Novel Complex of PD-L1 Aptamer and Holliday Junction Enhances Antitumor Efficacy in Vivo
por: Li, Ting, et al.
Publicado: (2021)

The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model
por: Young, Brittany A., et al.
Publicado: (2013)

Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?
por: Davola, Maria Eugenia, et al.
Publicado: (2019)

Selection of antitumor displayed peptides for the specific delivery of the anticancer drug lactaptin
por: Nemudraya, Anna Andreevna, et al.
Publicado: (2016)

CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy
por: Liu, Zuqiang, et al.
Publicado: (2015)

Combining IL-10 and Oncolytic Adenovirus Demonstrates Enhanced Antitumor Efficacy Through CD8(+) T Cells
por: Chen, Duo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nt72v75okg1a5q25s5uu77ol19